Science

Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Learn more about these therapeutic areas

Choose one of the following therapeutic areas in which we are dedicated at Sanofi

Cardiovascular

Diabetes

Atopic Dermatitis

Asthma

Nasal Polyps

Rare Diseases

Science

We offer you a 360º view of relevant and trustworthy content in our therapeutic areas

About Type 2 Inflammation - Nasal Polyps

About Type 2 Inflammation - Atopic Dermatitis

Influenza in Asthmatic Patients

About Type 2 Inflammation – Asthma

Influenza in Diabetic Patients

The BRIGHT Study

The Lixilan-L Study

Basal insulin and beyond

Covid-19 & Diabetes Treatment Guideline

SoliMix Study Results Summary Video

Hospitalization Rates for Acute Diabetes Complications

ODYSSEY Outcomes

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

Patient Case – Dupilumab in Atopic Dermatitis

Prevalence of Asthma

Asthma Assessment Tools (EPOS)

Asthma Control Tests (ACT) Overview

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

VTE prevention for acutely ill patients

HEART UK reviews safety of lipid-lowering medications in patients with COVID-19

What is the optimal way to assess VTE risk for high-risk medical patients?

Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?

Basal insulin and beyond

SoliMix Study Results Summary Video

ADA 2021: Solimix Trial Summary

Events

100 Years of Insulin

Dyslipidemia Webinar

VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Soliqua and Unmet Needs Webinar Summary

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

Prof. Caprini - Assessing the VTE Risk in Hospital And Beyond

VTE Safety Zone: Prof. Le Gal - The Role of Thromboprophylaxis for the Prevention of VTE

VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.